Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors. Its technologies are designed to be applied in a target and modality agnostic manner to chimeric antigen receptor (CAR), tumor-infiltrating lymphocytes (TIL), and T cell receptor (TCR) therapies. The company develops Gen-R and Epi-R technology platforms to develop a multi-modality product.
|HQ||South San Francisco, CA, US||Map|
When was Lyell founded?
Lyell was founded in 2018.
Who are Lyell key executives?
Lyell's key executives are Liz Homans, Richard Goold and Stephen Hill.
How many employees does Lyell have?
Lyell has 188 employees.
Who are Lyell competitors?
Competitors of Lyell include Jounce Therapeutics, Arvinas and NovoCure.
Where is Lyell headquarters?
Lyell headquarters is located at 201 Haskins Way, South San Francisco.
Where are Lyell offices?
Lyell has offices in South San Francisco, Bothell and Seattle.
How many offices does Lyell have?
Lyell has 3 offices.
Receive alerts for 300+ data fields across thousands of companies